Immunome, Inc.'s (NASDAQ:IMNM) Institutional Investors Lost 6.0% Last Week but Have Benefitted From Longer-term Gains
Immunome Insiders Added US$2.67m Of Stock To Their Holdings
STALICLA Appoints Dr. Purnanand Sarma, PhD, as Chair of the Board of Directors
Express News | Immunome Appoints Phil Tsai as Chief Technical Officer
Evaluating Immunome: Insights From 4 Financial Analysts
Immunome Initiated at Overweight by Piper Sandler
Express News | Piper Sandler Initiates Coverage On Immunome With Overweight Rating, Announces Price Target of $27
Immunome Analyst Ratings
Bullish Immunome Insiders Loaded Up On US$2.67m Of Stock
Immunome (NASDAQ:IMNM): An Opportunity for Investors With Strong Stomachs
Immunome(IMNM.US) Director Buys US$27,139.8 in Common Stock
Over $13M Bet On ProFrac Holding? Check Out These 4 Stocks Insiders Are Buying
Immunome(IMNM.US) Officer Buys US$1.39 Million in Common Stock
Express News | Immunome Shares Are Trading Higher After a Form4 Filing Showed President and CEO Clay Siegall Bought 100,000 Shares at an Average Price of $13.88 per Share
12 Health Care Stocks Moving In Tuesday's After-Market Session
Express News | Immunome Form 4 Filing Shows President And CEO Clay B Siegall Bought 100,000 Shares Of Stock At A Price Of $13.88/Share
Immunome Insider Bought Shares Worth $1,388,072, According to a Recent SEC Filing
Immunome Announces Completion of Purchase of Assets From Atreca
Immunome Appoints CFO
Express News | Immunome Announces Promotion of Max Rosett to Chief Financial Officer